title: Efficacy of omeprazole paste for prevention of gastric ulcers in horses in race training.
abstract: OBJECTIVE
  To determine the minimal effective dosage of omeprazole oral paste for the prevention of naturally occurring ulcers in horses starting race training.
  
  
  METHODS
  Prospective study.
  
  
  METHODS
  175 horses.
  
  
  METHODS
  Horses in the dose selection portion of the study were sham dose treated or received 1 mg (0.45 mg/lb) or 2 mg (0.9 mg/lb) of omeprazole/kg, PO, every 24 hours for 28 days or 4 mg of omeprazole/kg (1.8 mg/lb; loading dose), PO, every 24 hours for 4 days, then 1 or 2 mg of omeprazole/kg, PO, every 24 hours for 24 days. Horses in the dose confirmation portion of the study were sham dose treated or received 1 mg of omeprazole/kg, PO, every 24 hours for 28 days. Gastric ulcer scores at the beginning and end of the study were compared.
  
  
  RESULTS
  Sham-dose-treated horses had significantly higher ulcer scores than did horses treated with any of the omeprazole dosages evaluated. Among horses treated with omeprazole, there was no significant interaction of dose (1 or 2 mg/kg) and loading dose; therefore, the lowest effective dose (1 mg/kg) was evaluated in the dose confirmation portion of the study. In the dose confirmation study, 4 of 39 (10%) sham-dose-treated horses remained ulcer free, which was significantly different from the proportion of horses (31/38 [82%]) receiving 1 mg of omeprazole/kg that remained ulcer free. CONCLUSIONS AND CLINICAL RELEVANCE; Results indicated that omeprazole administered at a dosage of 1 mg/kg, PO, every 24 hours for 28 days was effective for prevention of gastric ulcers in horses starting race training.
authors.affiliation: College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250,USA.
authors.forename: Scott R
authors.initials: SR
authors.lastname: McClure
authors.forename: Gary W
authors.initials: GW
authors.lastname: White
authors.forename: Roger L
authors.initials: RL
authors.lastname: Sifferman
authors.forename: William
authors.initials: W
authors.lastname: Bernard
authors.forename: Michèle Y
authors.initials: MY
authors.lastname: Doucet
authors.forename: Andre
authors.initials: A
authors.lastname: Vrins
authors.forename: John E
authors.initials: JE
authors.lastname: Holste
authors.forename: Candis
authors.initials: C
authors.lastname: Fleishman
authors.forename: Roberto
authors.initials: R
authors.lastname: Alva
authors.forename: Luiz G
authors.initials: LG
authors.lastname: Cramer
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006734:Horse Diseases / Q000517:prevention & control*; D006736:Horses; D008297:Male; D009824:Ointments; D009853:Omeprazole / Q000008:administration & dosage*; D010805:Physical Conditioning, Animal / Q000009:adverse effects; D011446:Prospective Studies; D013276:Stomach Ulcer / Q000517:prevention & control / Q000662:veterinary*; D016896:Treatment Outcome
chemical_list: D000897:Anti-Ulcer Agents; D009824:Ointments; D009853:Omeprazole